Sidney Kennedy
0000-0001-5339-7185
10 papers found
Refreshing results…
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study
Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?
Childhood maltreatment and the clinical characteristics of major depressive disorder in adolescence and adulthood.
Personality and risk for serious mental illness
Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity – a consensus of the Biomarkers Task Force from the WFSBP
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort
Missing publications? Search for publications with a matching author name.